Article medical mushrooms psilocybin USA

How Cannabis and Psilocybin Might Help Some of the 50 Million Americans Who Are Experiencing Chronic Pain

The U.S. Drug Enforcement Agency announced in late April 2024 that it plans to ease federal restrictions on cannabis, reclassifying it from a Schedule I drug to the less restricted Schedule III, which includes drugs such as Tylenol with codeine, testos…